ASCO Reveals: Increasing Options For Relapse/ Refractory Patients In Haematological Malignancies
Hope for patients living with haematological malignancies; Immunotherapies represent a novel class of biologics
ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies

More Whitepapers / Newsletters

Diabetic Retinopathy Market
Diabetic Retinopathy

Diabetic retinopathy is an eye condition that leads to vision loss and blindness in people who have diabetes. In general, it is an asymptomatic and progressive micro-vascular diabetes complication tha...

Cancer Anorexia Market
Cancer Anorexia

Anorexia is the loss of the desire to eat, whereas cachexia results from the skeletal muscle mass in excess because of the weight loss. The reason for Anorexia can be Cancer, AIDS, a mental disorder (...

Current Treatment Challenges Of IO Refractory Patients And Clinical Development Of Therapies Targeting These Patients
Current Treatment Challenges O...

Over the years, the Oncology domain has experienced the entry of several treatment approaches. Therapeutic approaches such as surgery, radiation therapy, and chemotherapy form the conventional methods...

Schizophrenia Market

Schizophrenia is a severe mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions, and relate to others. It is a complex, long-term medical illness, af...

Anorexia Nervosa Market
Anorexia Nervosa

Anorexia Nervosa (AN) is a psychological condition that is characterized by an abnormally low weight, intense fear of gaining weight and distorted perception of body weight. It is prevalent in all dev...